206 related articles for article (PubMed ID: 35247847)
1. Modification of subcutaneous white adipose tissue inflammation by omega-3 fatty acids is limited in human obesity-a double blind, randomised clinical trial.
Fisk HL; Childs CE; Miles EA; Ayres R; Noakes PS; Paras-Chavez C; Kuda O; Kopecký J; Antoun E; Lillycrop KA; Calder PC
EBioMedicine; 2022 Mar; 77():103909. PubMed ID: 35247847
[TBL] [Abstract][Full Text] [Related]
2. Dysregulation of Subcutaneous White Adipose Tissue Inflammatory Environment Modelling in Non-Insulin Resistant Obesity and Responses to Omega-3 Fatty Acids - A Double Blind, Randomised Clinical Trial.
Fisk HL; Childs CE; Miles EA; Ayres R; Noakes PS; Paras-Chavez C; Antoun E; Lillycrop KA; Calder PC
Front Immunol; 2022; 13():922654. PubMed ID: 35958557
[TBL] [Abstract][Full Text] [Related]
3. Dysregulation of endocannabinoid concentrations in human subcutaneous adipose tissue in obesity and modulation by omega-3 polyunsaturated fatty acids.
Fisk HL; Childs CE; Miles EA; Ayres R; Noakes PS; Paras-Chavez C; Kuda O; Kopecký J; Antoun E; Lillycrop KA; Calder PC
Clin Sci (Lond); 2021 Jan; 135(1):185-200. PubMed ID: 33393630
[TBL] [Abstract][Full Text] [Related]
4. Rationale and design of a randomized controlled trial examining the effects of marine- and plant-sourced omega-3 fatty acid supplements on octadecanoid profiles and inflammation in females with obesity (OXBIO trial).
Rodway LA; Pauls SD; Aukema HM; Zahradka P; Taylor CG
Prostaglandins Leukot Essent Fatty Acids; 2021 Jul; 170():102284. PubMed ID: 34051428
[TBL] [Abstract][Full Text] [Related]
5. Dietary n-3 long chain PUFA supplementation promotes a pro-resolving oxylipin profile in the brain.
Rey C; Delpech JC; Madore C; Nadjar A; Greenhalgh AD; Amadieu C; Aubert A; Pallet V; Vaysse C; Layé S; Joffre C
Brain Behav Immun; 2019 Feb; 76():17-27. PubMed ID: 30086401
[TBL] [Abstract][Full Text] [Related]
6. Dietary EPA and DHA prevent changes in white adipose tissue omega-3 PUFA and oxylipin content associated with a Fads2 deficiency.
Sarr O; Payne GW; Hucik B; Abdelmagid S; Nakamura MT; Ma DWL; Mutch DM
J Nutr Biochem; 2019 Jan; 63():140-149. PubMed ID: 30368227
[TBL] [Abstract][Full Text] [Related]
7. The Omega-3 Fatty Acids EPA and DHA, as a Part of a Murine High-Fat Diet, Reduced Lipid Accumulation in Brown and White Adipose Tissues.
Soni N; Ross AB; Scheers N; Nookaew I; Gabrielsson BG; Sandberg AS
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31771283
[TBL] [Abstract][Full Text] [Related]
8. Effects of maternal n-3 fatty acid supplementation on placental cytokines, pro-resolving lipid mediators and their precursors.
Keelan JA; Mas E; D'Vaz N; Dunstan JA; Li S; Barden AE; Mark PJ; Waddell BJ; Prescott SL; Mori TA
Reproduction; 2015 Feb; 149(2):171-8. PubMed ID: 25504868
[TBL] [Abstract][Full Text] [Related]
9. Modulation of blood oxylipin levels by long-chain omega-3 fatty acid supplementation in hyper- and normolipidemic men.
Schuchardt JP; Schmidt S; Kressel G; Willenberg I; Hammock BD; Hahn A; Schebb NH
Prostaglandins Leukot Essent Fatty Acids; 2014; 90(2-3):27-37. PubMed ID: 24411718
[TBL] [Abstract][Full Text] [Related]
10. Omega-3 fatty acid supplementation influences the whole blood transcriptome in women with obesity, associated with pro-resolving lipid mediator production.
Polus A; Zapala B; Razny U; Gielicz A; Kiec-Wilk B; Malczewska-Malec M; Sanak M; Childs CE; Calder PC; Dembinska-Kiec A
Biochim Biophys Acta; 2016 Nov; 1861(11):1746-1755. PubMed ID: 27531277
[TBL] [Abstract][Full Text] [Related]
11. Divergent shifts in lipid mediator profile following supplementation with n-3 docosapentaenoic acid and eicosapentaenoic acid.
Markworth JF; Kaur G; Miller EG; Larsen AE; Sinclair AJ; Maddipati KR; Cameron-Smith D
FASEB J; 2016 Nov; 30(11):3714-3725. PubMed ID: 27461565
[TBL] [Abstract][Full Text] [Related]
12. Over-the-counter fish oil supplementation and pro-resolving and pro-inflammatory lipid mediators in rheumatoid arthritis.
Marchand NE; Choi MY; Oakes EG; Cook NR; Stevens E; Gomelskaya N; Kotler G; Manson JE; Lasky-Su J; Mora S; Lee IM; Tatituri R; Costenbader KH
Prostaglandins Leukot Essent Fatty Acids; 2023 Mar; 190():102542. PubMed ID: 36773395
[TBL] [Abstract][Full Text] [Related]
13. Changes in lipoprotein particle subclasses, standard lipids, and apolipoproteins after supplementation with n-3 or n-6 PUFAs in abdominal obesity: A randomized double-blind crossover study.
Grytten E; Laupsa-Borge J; Bohov P; Bjørndal B; Strand E; Skorve J; Nordrehaug JE; Berge RK; Rostrup E; Mellgren G; Dankel SN; Nygård OK
Clin Nutr; 2021 May; 40(5):2556-2575. PubMed ID: 33933722
[TBL] [Abstract][Full Text] [Related]
14. EPA and DHA differentially modulate monocyte inflammatory response in subjects with chronic inflammation in part via plasma specialized pro-resolving lipid mediators: A randomized, double-blind, crossover study.
So J; Wu D; Lichtenstein AH; Tai AK; Matthan NR; Maddipati KR; Lamon-Fava S
Atherosclerosis; 2021 Jan; 316():90-98. PubMed ID: 33303222
[TBL] [Abstract][Full Text] [Related]
15. Oxylipin status, before and after LC n-3 PUFA supplementation, has little relationship with skeletal muscle biology in older adults at risk of sarcopenia.
de Marco Castro E; Kampschulte N; Murphy CH; Schebb NH; Roche HM
Prostaglandins Leukot Essent Fatty Acids; 2023 Feb; 189():102531. PubMed ID: 36645979
[TBL] [Abstract][Full Text] [Related]
16. Increase of EPA-derived hydroxy, epoxy and dihydroxy fatty acid levels in human plasma after a single dose of long-chain omega-3 PUFA.
Schuchardt JP; Schneider I; Willenberg I; Yang J; Hammock BD; Hahn A; Schebb NH
Prostaglandins Other Lipid Mediat; 2014 Jun; 109-111():23-31. PubMed ID: 24667634
[TBL] [Abstract][Full Text] [Related]
17. Omega-3 fatty acids and adipose tissue biology.
Kuda O; Rossmeisl M; Kopecky J
Mol Aspects Med; 2018 Dec; 64():147-160. PubMed ID: 29329795
[TBL] [Abstract][Full Text] [Related]
18. Comparative study of tissue deposition of omega-3 fatty acids from polar-lipid rich oil of the microalgae Nannochloropsis oculata with krill oil in rats.
Kagan ML; Levy A; Leikin-Frenkel A
Food Funct; 2015 Jan; 6(1):186-92. PubMed ID: 25360534
[TBL] [Abstract][Full Text] [Related]
19. Enriched Marine Oil Supplement Increases Specific Plasma Specialized Pro-Resolving Mediators in Adults with Obesity.
Al-Shaer AE; Regan J; Buddenbaum N; Tharwani S; Drawdy C; Behee M; Sergin S; Fenton JI; Maddipati KR; Kane S; Butler E; Shaikh SR
J Nutr; 2022 Jul; 152(7):1783-1791. PubMed ID: 35349683
[TBL] [Abstract][Full Text] [Related]
20. Similar eicosapentaenoic acid and docosahexaenoic acid plasma levels achieved with fish oil or krill oil in a randomized double-blind four-week bioavailability study.
Yurko-Mauro K; Kralovec J; Bailey-Hall E; Smeberg V; Stark JG; Salem N
Lipids Health Dis; 2015 Sep; 14():99. PubMed ID: 26328782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
